as on October 28, 2025 at 1:29 am IST
Day's Low
Day's High
6.23%
Downside
0.97%
Upside
52 Week's Low
52 Week's High
65.07%
Downside
1.99%
Upside
Check Arcus Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
-3.7047
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.36
Industry PE ratio
-0.8809294871794872
PEG Ratio
0EBITDA
-328.0M
Revenue (TTM)
262.0M
Profit Margin
-113.74%
Return On Equity TTM
-50.34%
Track how Arcus Biosciences Inc P/E has moved over time to understand its valuation trends.
Arcus Biosciences Inc in the last 5 years
Lowest (-12.43x)
March 31, 2021
Today (-6.36x)
October 28, 2025
Industry (-0.88x)
October 28, 2025
Highest (90.21x)
December 31, 2021
Today’s Price to Earnings Ratio: -6.36x
Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | -9.27% | -6.36 | -113.74% | |
| BUY | $60.7B | 283.23% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 101.68% | 29.95 | 31.86% | |
| BUY | $61.3B | 3.22% | 14.55 | 31.37% |
The Arcus Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Arcus Biosciences Inc investment value today
Current value as on today
₹1,16,779
Returns
₹16,779
(+16.78%)
Returns from Arcus Biosciences Inc Stock
₹11,705 (+11.7%)
Dollar Returns*
₹5,074 (+5.07%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Arcus Biosciences Inc. Average target price of $31.27
Get share price movements and forecasts by analysts on Arcus Biosciences Inc.
What analysts predicted
40.49%UPSIDE
Target Price
$31.27
Current Price
$18.61
Analyzed by
18 Analysts
Target
$31.27
Arcus Biosciences Inc target price $31.27, a slight upside of 40.49% compared to current price of $18.61. According to 18 analysts rating.
Search interest for Arcus Biosciences Inc Stock has increased by 1133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1133% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -112.0M → -8.0M (in $), with an average increase of 1300.0% per quarter
Price Rise
![]()
In the last 1 month, RCUS stock has moved up by 34.8%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 26.0M → 160.0M (in $), with an average increase of 44.8% per quarter
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.5% return, outperforming this stock by 57.6%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.6% return, outperforming this stock by 164.2%
| Organisation | Arcus Biosciences Inc |
| Headquarters | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
| Industry | Health Technology |
| CEO | Dr. Terry J. Rosen Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Alexander Azoy CPA | VP of Finance & Principal Accounting Officer |
Ms. Carolyn C. Tang J.D. | General Counsel & Corporate Secretary |
Holli Kolkey | Vice President of Corporate Communications |
Mr. Robert C. Goeltz II | Principal Financial Officer & CFO |
Ms. Jennifer A. Jarrett M.B.A. | Chief Operating Officer |
Dr. K. Christopher Garcia Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Pia Eaves | Vice President of Investor Relations & Strategy |
Dr. Terry J. Rosen Ph.D. | Co-Founder, Chairman & CEO |
Dr. Juan Carlos Jaen Ph.D. | Co- Founder & President |
Dr. Jonathan Yingling Ph.D. | Chief Scientific Officer |
Arcus Biosciences Inc share price today is $18.61 as on at the close of the market. Arcus Biosciences Inc share today touched a day high of $18.79 and a low of $17.45.
Arcus Biosciences Inc share touched a 52 week high of $18.98 on and a 52 week low of $6.5 on . Arcus Biosciences Inc stock price today i.e. is closed at $18.61,which is 1.95% down from its 52 week high and 186.31% up from its 52 week low.
Arcus Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Arcus Biosciences Inc (RCUS) shares with as little as ₹88.189 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Arcus Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcus Biosciences Inc share’s latest price of $18.61 as on October 28, 2025 at 1:29 am IST, you will get 0.5373 shares of Arcus Biosciences Inc. Learn more about
fractional shares .
Arcus Biosciences Inc stock has given -9.27% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?